Account (1,4-Diazabicyclo[2.2.2]octan-1-ium-1-ylsulfonyl)(tert-butoxycarbonyl)amide compound with 1,4-diazabicyclo[2.2.2]octane (1:1) hydrochloride
- Catalog No. :
- ACMGLB543
- CAS No. :
- 1858278-48-4
- Molecular Formula :
- C17H34ClN5O4S
- Molecular Weight :
- 440.01
IUPAC Name:((1,4-diazabicyclo[2.2.2]octan-1-ium-1-yl)sulfonyl)(tert-butoxycarbonyl)amide--1,4-diazabicyclo[2.2.2]octane (1/1) hydrochloride
![(1,4-Diazabicyclo[2.2.2]octan-1-ium-1-ylsulfonyl)(tert-butoxycarbonyl)amide compound with 1,4-diazabicyclo[2.2.2]octane (1:1) hydrochloride structure diagram](/images/productimg/no-pic.svg)
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$178.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (1,4-Diazabicyclo[2.2.2]octan-1-ium-1-ylsulfonyl)(tert-butoxycarbonyl)amide compound with 1,4-diazabicyclo[2.2.2]octane (1:1) hydrochloride |
|---|---|
| IUPAC Name | ((1,4-diazabicyclo[2.2.2]octan-1-ium-1-yl)sulfonyl)(tert-butoxycarbonyl)amide--1,4-diazabicyclo[2.2.2]octane (1/1) hydrochloride |
| MDL No. | - |
| Molecular Formula | C17H34ClN5O4S |
| Molecular Weight | 440.01 |
| SMILES | O=S([N+]1(CC2)CCN2CC1)([N-]C(OC(C)(C)C)=O)=O.[H]Cl.N3(CC4)CCN4CC3 |
| InChI Key | XUOBRPCZSCIKCZ-UHFFFAOYSA-N |
| Synonym | ((1,4-Diazabicyclo[2.2.2]octan-1-ium-1-yl)sulfonyl)(tert-butoxycarbonyl)amide DABCO adduct;(1,4-Diazabicyclo[2.2.2]octan-1-ium-1-ylsulfonyl)(tert-butoxycarbonyl)amide compound with 1,4-diazabicyclo[2.2.2]octane (1:1) hydrochloride;(E)-tert-Butyl 1,4-Diazabicyclo[2.2.2]octan-1-ium-1-ylsulfonylcarbonimidate compound with 1,4-Diazabicyclo[2.2.2]octane (1:1) Hydrochloride;1-Aza-4-azoniabicyclo[2.2.2]octan-4-ylsulfonyl(tert-butoxycarbonyl)azanide DABCO adduct - [A8666] |
| CAS No. | 1858278-48-4 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338
